Dewei Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dewei Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Qiang Wang
Department of Thyroid Surgery, Shanxi Provincial People’s Hospital, Taiyuan, China
2 shared publicationsZebin Hou
Department of Thyroid Surgery, Shanxi Provincial People’s Hospital, Taiyuan, China
2 shared publicationsZhifu Xiao
Department of Thyroid Surgery, Shanxi Provincial People’s Hospital, Taiyuan, China
2 shared publications- Bo Yu
Department of Medicine, Beijing USCI Medical Laboratory, Beijing, China
1 shared publication Dongliang Wang
Department of Thyroid Surgery, Shanxi Provincial People’s Hospital, Taiyuan, China
1 shared publicationHongjing Meng
Department of Thyroid Surgery, Shanxi Provincial People’s Hospital, Taiyuan, China
1 shared publication
Latest Publications
- Open Access
- 19 June 2024
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 28 (5) , 601-609
Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features
Background Thyroid cancer is prevalent worldwide, including in China, where its incidence is on the rise. Papillary thyroid carcinoma (PTC) is the predominant subtype. Investigating the relationship between clinical data associated with PTC and gene mutations is crucial for improving detection and treatment. Patients and Methods We collected samples and associated clinical data from 700 PTC patients at Shanxi Provincial People’s Hospital. Using a panel of 57 genes linked to thyroid cancer, we sequenced the samples to determine the mutation frequency of thyroid cancer-associated genes in PTC. We further analyzed the correlation between gene variants and clinical information. Results The mean age of patients in this study was 42.5 years. Females predominated, comprising 507 of the total patient population, resulting in a female-to-male ratio of 2.63 (507:193). Tumor distribution revealed 198, 257, and 142 cases on the left, right, and both sides, respectively. Among the 57 thyroid cancer-related genes analyzed, we identified at least one driver gene in 83.6% of patients. Notably, 76.4% had BRAF mutations, mainly BRAFV600E, which constituted 90.9% of all BRAF mutations, with 535 cases exhibiting these mutations. Other significant driver genes included CHEK2 (n = 84), RET (n = 42), PIK3CA (n = 7), and EGFR (n = 7). RET fusions (n = 28) were also identified. Notably, patients under 55 years old exhibit a higher tendency towards advanced N staging, suggesting that younger individuals may be more prone to lymph node metastasis. Additionally, male patients were more likely to have advanced N stages. Importantly, a positive correlation was observed between higher BRAF allele frequencies and more advanced T and N stages. Similarly, correlation analysis revealed that a greater frequency of RET fusions correlated with later T and N stages. Conclusion This study uncovered several significant insights. Younger PTC patients exhibited a higher propensity for lymph node metastasis. An elevated mutation frequency of BRAF was correlated with a higher occurrence of RET fusions, predisposing individuals to lymph node metastasis and potentially indicating a poorer prognosis.
- 19 June 2024
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 28 (5) , 601-609
Open AccessPapillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features
Background Thyroid cancer is prevalent worldwide, including in China, where its incidence is on the rise. Papillary thyroid carcinoma (PTC) is the predominant subtype. Investigating the relationship between clinical data associated with PTC and gene mutations is crucial for improving detection and treatment. Patients and Methods We collected samples and associated clinical data from 700 PTC patients at Shanxi Provincial People’s Hospital. Using a panel of 57 genes linked to thyroid cancer, we sequenced the samples to determine the mutation frequency of thyroid cancer-associated genes in PTC. We further analyzed the correlation between gene variants and clinical information. Results The mean age of patients in this study was 42.5 years. Females predominated, comprising 507 of the total patient population, resulting in a female-to-male ratio of 2.63 (507:193). Tumor distribution revealed 198, 257, and 142 cases on the left, right, and both sides, respectively. Among the 57 thyroid cancer-related genes analyzed, we identified at least one driver gene in 83.6% of patients. Notably, 76.4% had BRAF mutations, mainly BRAFV600E, which constituted 90.9% of all BRAF mutations, with 535 cases exhibiting these mutations. Other significant driver genes included CHEK2 (n = 84), RET (n = 42), PIK3CA (n = 7), and EGFR (n = 7). RET fusions (n = 28) were also identified. Notably, patients under 55 years old exhibit a higher tendency towards advanced N staging, suggesting that younger individuals may be more prone to lymph node metastasis. Additionally, male patients were more likely to have advanced N stages. Importantly, a positive correlation was observed between higher BRAF allele frequencies and more advanced T and N stages. Similarly, correlation analysis revealed that a greater frequency of RET fusions correlated with later T and N stages. Conclusion This study uncovered several significant insights. Younger PTC patients exhibited a higher propensity for lymph node metastasis. An elevated mutation frequency of BRAF was correlated with a higher occurrence of RET fusions, predisposing individuals to lymph node metastasis and potentially indicating a poorer prognosis.
- 4 February 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 129, 111605
Effect of disulfidptosis-related genes SLC3A2, SLC7A11 and FLNB polymorphisms on risk of autoimmune thyroiditis in a Chinese population
- 4 February 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 129, 111605
Effect of disulfidptosis-related genes SLC3A2, SLC7A11 and FLNB polymorphisms on risk of autoimmune thyroiditis in a Chinese population